RemediumOne congratulates Prof. Asita de Silva, founder of RemediumOne, on being awarded the Fellowship of the British Pharmacological Society (BPS) for 2024. This recognition reflects his contributions to pharmacology and clinical research in Sri Lanka and globally.

The British Pharmacological Society Fellowship is awarded to individuals who have made a sustained impact on pharmacology through research, education, and leadership. Prof. de Silva’s work in clinical trials, regulatory science, and public health policy has contributed to advancements in drug development and healthcare.

As a Professor in the Faculty of Medicine at the University of Kelaniya, he has played a role in developing Sri Lanka’s clinical research landscape. Under his leadership, RemediumOne has expanded its clinical research activities, conducting international clinical trials that support evidence-based medicine.

This recognition by the British Pharmacological Society highlights Prof. de Silva’s role in research and capacity building in Sri Lanka and beyond. RemediumOne acknowledges his contributions and extends its congratulations.

UOK Today – Professor Asita de Silva Honoured as a Fellow of the British Pharmacological Society for 2024

Recent Blogs
𝗥𝗲𝗺𝗲𝗱𝗶𝘂𝗺𝗢𝗻𝗲 𝗮𝘁 𝗚𝗣𝗛𝗦 𝟮𝟬𝟮𝟱 – 𝗗𝗿𝗶𝘃𝗶𝗻𝗴 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗩𝗲𝗰𝘁𝗼𝗿-𝗕𝗼𝗿𝗻𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻
July 22, 2025
U.S. FDA Approves KERENDIA (finerenone) to treat patients with left ventricular ejection fraction ≥ 40%
July 17, 2025
RemediumOne Joins as Founding Member of the COGNITUM ARO Consortium
June 24, 2025
Make a different tomorrow
Get in touch with us